Haploidentical hematopoietic stem cell transplantation for nonresponders to immunosuppressive therapy against acquired severe aplastic anemia

Bone Marrow Transplant. 2016 Mar;51(3):424-7. doi: 10.1038/bmt.2015.249. Epub 2015 Oct 19.

Authors

L Liu^{1

2}, X Wang¹, S Jin¹, L Hao³, Y Zhang², X Zhang², D Wu¹

Affiliations

¹ Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Collaborative Innovation Center of Hematology, Jiangsu Institute of Hematology, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
² Department of Hematology, The Second People's Hospital of Huai'an, Huai'an, China.
³ Department of Hematology, The People's Hospital of Peixian, Peixian, China.

PMID: 26479978
DOI: 10.1038/bmt.2015.249

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Anemia, Aplastic / mortality*
Anemia, Aplastic / therapy*
Child
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation*
Humans
Immunosuppression Therapy*
Male
Retrospective Studies
Severity of Illness Index
Survival Rate